8-K: Grace Therapeutics, Inc. Completes Corporate Name Change and Ticker Symbol Update

Grace Therapeutics, Inc. has officially changed its name from Acasti Pharma Inc. and updated its ticker symbol on the Nasdaq Stock Market.

Summary

• Grace Therapeutics, Inc. has changed its name from Acasti Pharma Inc. effective October 28, 2024.
• The company's common stock now trades on the Nasdaq under the ticker symbol GRCE, replacing the previous symbol ACST.
• The name change was formalized through a certificate of amendment filed with the State of Delaware on October 24, 2024.
• The company's bylaws were also amended to reflect the new name, effective October 28, 2024.
• The CUSIP number for the company's common stock remains unchanged at 00439U104.
• The name change does not affect the rights of the company's security holders.

Sentiment

Score: 7

Explanation: The document reflects a neutral corporate action, a name change, which is neither positive nor negative in itself. The sentiment is therefore neutral to slightly positive as it is a step in the company's evolution.

Positives

• The name change and ticker symbol update are a part of the company's rebranding efforts.
• The CUSIP number remaining the same ensures continuity for security holders.
• The company has taken all necessary legal steps to formalize the name change.

Management Comments

• Prashant Kohli, Chief Executive Officer, signed the report on behalf of Grace Therapeutics, Inc.

Industry Context

Name changes and ticker symbol updates are common corporate actions, often associated with rebranding or strategic shifts. This change reflects a new identity for the company.

Comparison to Industry Standards

• The process of changing a company name and ticker symbol is a standard corporate procedure, and Grace Therapeutics followed the typical steps of filing a certificate of amendment and updating its bylaws.
• Other companies that have undergone similar name changes include Facebook to Meta, and Google to Alphabet, although these were much larger and more complex changes.
• The process of updating the ticker symbol with Nasdaq is also a standard procedure, and the company's actions are consistent with industry norms.

Corporate Governance

Stakeholder Impact

• Shareholders will need to be aware of the new ticker symbol, GRCE, when trading the company's stock.
• The name change may impact the company's brand perception and recognition in the market.
• The CUSIP number remaining the same ensures continuity for security holders.

Key Dates

Keywords

Grace Therapeutics, Acasti Pharma, name change, ticker symbol, GRCE, ACST, Nasdaq, corporate action